HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cross-protective and cross-reactive immune responses to recombinant vaccinia viruses expressing full-length lyssavirus glycoprotein genes.

Abstract
Lyssaviruses cause acute, progressive encephalitis in mammals. Current rabies vaccines offer protection against the lyssaviruses, with the notable exceptions of Mokola virus (MOKV), Lagos bat virus (LBV) and West Caucasian bat virus (WCBV). Here we describe the cross-protective and cross-reactive immune responses induced by experimental recombinant vaccinia viruses encoding the glycoprotein genes of rabies virus (RABV), MOKV and WCBV, either singly or in dual combinations. Constructs expressing a single glycoprotein gene protected mice against lethal intracranial challenge with homologous virus. Similarly, recombinants expressing glycoprotein genes from two different lyssaviruses offered mice protection against both homologous viruses. VNAb induced by vaccines that included a MOKV glycoprotein gene cross-neutralized LBV, but not WCBV. We concluded that a single recombinant poxvirus-vectored vaccine including MOKV and RABV glycoprotein genes, should be a major addition to available rabies biologics and should offer broad protection against all of the lyssaviruses, except WCBV.
AuthorsJ Weyer, I V Kuzmin, C E Rupprecht, L H Nel
JournalEpidemiology and infection (Epidemiol Infect) Vol. 136 Issue 5 Pg. 670-8 (May 2008) ISSN: 0950-2688 [Print] England
PMID17588277 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Viral
  • Rabies Vaccines
  • Viral Proteins
  • Viral Vaccines
Topics
  • Animals
  • Antibodies, Viral (immunology)
  • Cross Reactions
  • Female
  • Lyssavirus (genetics, immunology)
  • Mice
  • Neutralization Tests
  • Rabies (immunology, prevention & control)
  • Rabies Vaccines (genetics, immunology)
  • Vaccinia virus (genetics, immunology)
  • Viral Proteins (genetics, immunology)
  • Viral Vaccines (genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: